SYRACUSE, N.Y. (WTEN) People who suffer from migraines are going to have a harder time getting relief from the pain.
Some drug stores across the country aren’t able to stock up on the drug Excedrin.
This is because the company that makes the drug has temporarily stopped production.
One person who relies on the drug says that a shortage of Excedrin will mean it will be harder to fight the pain from a migraine.
“I’ve been suffering for about 10 years. I’ve gone to the doctor’s. I’ve tried prescription medicines. I had Botox. I’ve tried medical marijuana and I still end up going back to Excedrin,” Ashleigh Eldred said.
The company says they stopped production over “inconsistencies in how we transfer and weigh ingredients.”
GlaxoSmithKline reminds customers its other products are likely still available, like “Tension Headache” and “PM Headache,” along with other brands and generic forms of pain-relieving drugs.
The company and independent pharmacists advise customers to consult their pharmacists for the best alternative.
Complete statement from GlaxoSmithKline:
“Patient safety and product quality are our utmost priorities at GSK. Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs and Excedrin Migraine Caplets and Geltabs. Based on the available data, GSK believes that the product, does not pose a safety risk to consumers. However, as a precautionary measure, GSK Consumer Healthcare has voluntarily implemented a discontinuation of production and distribution. We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume. Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.“
KATHLEEN BEATTY
AMERICAS HEAD OF COMMUNICATIONS AND GOVERNMENT AFFAIRS
GSK CONSUMER HEALTHCARE
